Skip to content

Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders

Impact of a Transportable Customizable and Scalable Sitting Positioning Device on Swallowing Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02457052
Acronym
DATP-DEG
Enrollment
64
Registered
2015-05-29
Start date
2014-10-31
Completion date
2018-03-31
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deglutition Disorders

Keywords

Medical device

Brief summary

When the seat is a vehicle for disabled person, postural adaptation methodology is known and, on prescription, there is possibility of financial support for technical posture assists. For people who use a standard seat, a chair for example, there is no satisfactory existing hardware. A transportable customisable and scalable sitting positioning device (DATP device), to be placed on a standard seat, is a solution that might fit in the home, in specialized foster homes or in institutions for the elderly. Such a device has been developed but earnings on swallowing disorders have to be validated.

Interventions

DEVICEDATP

Medical device allowing a custom sitting to help patients with swallowing disorders

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

: * Present a swallowing disorder authenticated by a score Dysphagia Handicap Index above 11 * Postural disorder authenticated by a score greater than 0 to at least 1 of the following 3 items to MCPAA: retroversion, obliquity and rotation of the pelvis * Autonomy Conservation compatible with the use of different seats including standard seats * Signing of informed consent

Exclusion criteria

* Postural disorder requiring the use of only one type of installation (wheelchair or hull) * Spinal stiffness or non-reducible hips (spondylitis, osteosynthesis rod) * Not included anthropometric dimensions between: * Basin with between 39 and 50 cm * femoral length between 42 and 52 cm * tibial length between 39 and 44 cm (46.5 with femoral recharge), measured with the shoes. * Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline in laryngeal movement during swallowingOne monthCompare the laryngeal movement during swallowing in dysphagic population with DATP device compare to a population without device after one month of care. At Visit 1, patients were included and randomized 1 month later the patients in both groups will be invited for specific education session positioning. The introduction of the device will be carried out before the meeting for patients DATP + group, which will include a training session in the use of DATP. Patients who have the DATP will be contacted by telephone within the first 15 days to verify compliance with the use of the device. All patients returned 1 month for the last visit.

Secondary

MeasureTime frameDescription
NIH Swallowing Safety ScaleOne monthThe secondary outcomes are to evaluate the impact on other characteristics of swallowing, the posture, the acceptability of the device and the quality of life. Comparison before and after the treatment of dysphagia population with DATP compared to a population dysphagia.
Functional oral intake scale (FOIS)One month
Adult sitting postural control measure (MCPAA)One month
Quality questionnaire of patient's lifeOne monthUsing Short Form (36) Health Survey (SF-36)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026